Merck goes lean; McKesson to deliver H1N1 vaccine;

> A new supply strategy intended to yield a "leaner, more cost-able and buyer-focused manufacturing model" at the Merck Manufacturing Division is the goal of an international restructuring program. Announcement

> The CDC is upping its reliance on McKesson. The big-three drug distributor's assignment now includes delivery of H1N1 vaccine to some 90,000 sites, in addition to the distribution of public-sector purchased adult and pediatric vaccines. Release

> Analysis of novel marine microbes could lead to more efficient and greener ways to manufacture drugs. Release

> A new version the EudraGMP database provides public access to information about manufacturing, importation authorizations and good manufacturing practice certificates. Release

> As Caraco learns of another class action lawsuit filed against it for misleading investors concerning GMP lapses, an investment advisory concern finds the company "underappreciated and undervalued." Story